ORCL vs TECH · P/E 31, rev $67.36B vs P/E 65, rev $1.22B
Oracle Corporation (ORCL) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Oracle Corporation (ORCL) is a software - infrastructure company listed on NYSE. It is led by Safra Catz.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported ORCL revenue for 2026-05-31 was $67.36B. Net income was $17.09B. Revenue was up 17.3% from 2025-05-31 to 2026-05-31. ORCL currently screens at market cap $527.84B and trailing P/E 31.4.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
ORCL currently screens at market cap $527.84B and trailing P/E 31.4. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the ORCL and TECH stock pages for the full models.
Not investment advice.